Functional Gene Expression Signatures from On-Treatment Tumor Specimens Predict Anti-PD1 Blockade Response in Metastatic Melanoma

Functional Gene Expression Signatures from On-Treatment Tumor Specimens Predict Anti-PD1 Blockade Response in Metastatic Melanoma

Functional gene expression signatures (FGES) from pretreatment biopsy samples have been used to predict the responses of metastatic melanoma to immune checkpoint blockade (ICB) therapies. However, there are no predictive FGE signatures from patients receiving treatment. Here, using the Elastic Net R...

Full description

Bibliographic Details
Main Authors:	Shuzhao Chen, Limei Zhang, Haocheng Lin, Yang Liang, Yun Wang
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Biomolecules
Subjects:	functional gene expression signatures on-treatment tumor specimens anti-PD1 blockade response metastatic melanoma
Online Access:	https://www.mdpi.com/2218-273X/13/1/58

Similar Items

Immunogenic cell death signatures from on-treatment tumor specimens predict immune checkpoint therapy response in metastatic melanoma
by: Huancheng Zeng, et al.
Published: (2024-10-01)

Unmasking of intracranial metastatic melanoma during ipilimumab/nivolumab therapy: case report and literature review
by: Marin A. McDonald, et al.
Published: (2018-05-01)

PD-L1 Tumor Expression as a Predictive Biomarker of Immune Checkpoint Inhibitors’ Response and Survival in Advanced Melanoma Patients in Brazil
by: Bruna Pereira Sorroche, et al.
Published: (2023-03-01)

The age of enlightenment in melanoma immunotherapy
by: Mark R. Albertini
Published: (2018-08-01)

PEMBROLIZUMAB IN THE TREATMENT OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2017-06-01)

Lenvatinib Monotherapy Versus Lenvatinib in Combination with PD-1 Blockades as Re-Challenging Treatment for Patients with Metastatic Osteosarcoma: A Real-World Study
by: Song G, et al.
Published: (2025-02-01)

Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic melanoma
by: Simona Serratì, et al.
Published: (2023-09-01)

BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
by: Karam Khaddour, et al.
Published: (2021-06-01)

Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
by: Elias A. T. Koch, et al.
Published: (2024-06-01)

An estrogen response-related signature predicts response to immunotherapy in melanoma
by: Min Lin, et al.
Published: (2023-05-01)

Role of Surgery in Metastatic Melanoma and Review of Melanoma Molecular Characteristics
by: Kulkaew Sukniam, et al.
Published: (2024-03-01)

Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
by: Andrea Gaißler, et al.
Published: (2022-07-01)

Paraneoplastic acral vascular syndrome in a patient with metastatic melanoma under immune checkpoint blockade
by: Thilo Gambichler, et al.
Published: (2017-05-01)

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma
by: Ronen Stoff, et al.
Published: (2023-05-01)

METASTATIC MALIGNANT MELANOMA OF THE BREAST: A CASE REPORT
by: Olcay Ak Nalbant, et al.
Published: (2011-01-01)

Combination high-dose interleukin-2 and nivolumab for programmed cell death-1 refractory metastatic melanoma: a case series
by: Mina Nikanjam, et al.
Published: (2022-08-01)

Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study
by: Bai H, et al.
Published: (2024-02-01)

Metastatic Malignant Melanoma of the Gastrointestinal Tract: Too Dark to be Seen?
by: Jéssica Chaves, et al.
Published: (2022-10-01)

Targeted deletion of CD244 on monocytes promotes differentiation into anti-tumorigenic macrophages and potentiates PD-L1 blockade in melanoma
by: Jeongsoo Kim, et al.
Published: (2024-02-01)

Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma
by: Teresa Kim, et al.
Published: (2014-12-01)

Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis
by: Jingjing Zhao, et al.
Published: (2022-12-01)

Primary metastatic melanoma of the female urethra mimicking a benign urethral caruncle: A case report
by: Sami Chebbi, et al.
Published: (2024-09-01)

Metastatic melanoma posing as a pelvic mass
by: Alexsaundra Zywicki, et al.
Published: (2023-02-01)

Metastatic melanoma to the proximal ureter
by: Matthew DeSanto, et al.
Published: (2023-09-01)

M1-like TAMs are required for the efficacy of PD-L1/PD-1 blockades in gastric cancer
by: Rui Zhao, et al.
Published: (2021-01-01)

Treatment of Metastatic Melanoma at First Diagnosis: Review of the Literature
by: Miguel-Angel Berciano-Guerrero, et al.
Published: (2022-08-01)

The features of leptin and its receptor expression in metastatic cutaneous melanoma
by: A. A. Lushnikova, et al.
Published: (2015-06-01)

Primary Dermal Melanoma: A Rare Clinicopathological Variant Mimicking Metastatic Melanoma
by: Oriana Simonetti, et al.
Published: (2021-02-01)

An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy—a retrospective cohort study examining 66 circulating immune cell subsets
by: Peidong Chi, et al.
Published: (2022-12-01)

Modification of the Tumor Microenvironment Enhances Anti-PD-1 Immunotherapy in Metastatic Melanoma
by: Guilan Shi, et al.
Published: (2022-11-01)

IPILIMUMAB IN THERAPY OF METASTATIC MELANOMA
by: I. V. SAMOILENKO, et al.
Published: (2016-12-01)

Validation of an Ultraviolet Light Response Gene Signature for Predicting Prognosis in Patients with Uveal Melanoma
by: Carlos A. Orozco, et al.
Published: (2023-07-01)

The forgotten appearance of metastatic melanoma in the small bowel
by: Eva Mendes Serrao, et al.
Published: (2022-06-01)

Clinical significance of <it>BRAF </it>mutations in metastatic melanoma
by: Polsky David, et al.
Published: (2004-12-01)

Metastatic amelanotic malignant melanoma in a patient with oculocutaneous albinism: A rare presentation
by: Geeta Sharma, et al.
Published: (2023-01-01)

A Case of Metastatic Melanoma Presenting as a Small Bowel Obstruction
by: Danielle Harris, et al.
Published: (2022-07-01)

Metastatic Anorectal Melanoma Presenting as Seizures: An Infrequent Culprit
by: Joao Galante, et al.
Published: (2022-04-01)

High-Dose Ascorbate in Combination with Anti-PD1 Checkpoint Inhibition as Treatment Option for Malignant Melanoma
by: Markus Burkard, et al.
Published: (2023-01-01)

Overcoming melanoma resistance to immune checkpoint blockade therapy using nano-strategies
by: Yiqin Ding, et al.
Published: (2023-12-01)

Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade
by: Shuming Chen, et al.
Published: (2024-03-01)